SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : sciclone pharmaceuticals
SCLN 11.150.0%Oct 20 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Captain Jack who wrote (995)11/6/2001 12:13:17 PM
From: Skywatcher  Read Replies (1) of 1137
 
WASHINGTON (Dow Jones)Sciclone Pharmaceuticals Inc. (SCLN) filed to sell up to $20 million of common stock, preferred stock, debt and warrants from time to time under a shelf registration statement filed Tuesday with the Securities and Exchange Commission.

The company will provide details of the securities in a future prospectus.

The company intends to use the net proceeds from the offering for working capital and other corporate purposes including research and development, financing growth, payment of capital expenditures and the repayment of debt.

No underwriters were listed in the filing.

Sciclone Pharmaceuticals buys, develops and markets pharmaceuticals in the U.S. and abroad.

looks like they are gearing up to rip us off even more.
what ARE they doing with those salaries??????
CC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext